GlassScriptPhysician profile
Jessica L Boyer
NPI 1558883439
$1,821.06
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $324 · 2022: $287 · 2023: $1,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $475.09 | 2021-2023 | Spaceoar Vue System - 10ml, Rezum Generator, Ams 700 Cxr Rte Kit |
| Astellas Pharma US INC | $230.68 | 2021-2023 | Xtandi |
| Pfizer INC. | $176.72 | 2021-2023 | |
| Blue Earth Diagnostics | $173.21 | 2021-2023 | |
| Urogen Pharma, INC. | $156.35 | 2023 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $126.71 | 2021-2023 | Prolaris |
| Abbvie INC. | $78.82 | 2022-2023 | |
| Urovant Sciences INC | $77.65 | 2021-2022 | |
| Tolmar, INC. | $52.34 | 2023 | |
| Convatec INC. | $43.56 | 2021 | |
| Abiomed | $40.08 | 2023 | Impella |
| Tolmar Pharmaceuticals, INC. | $39.15 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $30.23 | 2022 | |
| Teleflex LLC | $28.21 | 2023 | Urolift |
| Progenics Pharmaceuticals, INC. | $24.18 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $18.06 | 2021 | |
| Sumitomo Pharma America, INC. | $17.44 | 2023 | Gemtesa |
| Ambu INC. | $17.10 | 2022 | |
| Clarus Therapeutics INC. | $15.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Boyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.